282 related articles for article (PubMed ID: 26715272)
1. Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion.
Jiang Y; Han Y; Sun C; Han C; Han N; Zhi W; Qiao Q
Tumour Biol; 2016 Jun; 37(6):8131-8. PubMed ID: 26715272
[TBL] [Abstract][Full Text] [Related]
2. Rab11 Functions as an Oncoprotein via Nuclear Factor kappa B (NF-κB) Signaling Pathway in Human Bladder Carcinoma.
Gong X; Liu J; Zhang X; Dong F; Liu Y; Wang P
Med Sci Monit; 2018 Jul; 24():5093-5101. PubMed ID: 30032159
[TBL] [Abstract][Full Text] [Related]
3. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
Tan ST; Liu SY; Wu B
Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
[TBL] [Abstract][Full Text] [Related]
4. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
Yu L; Li X; Li H; Chen H; Liu H
Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
[TBL] [Abstract][Full Text] [Related]
5. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
[TBL] [Abstract][Full Text] [Related]
6. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-367-3p directly targets RAB23 and inhibits proliferation, migration and invasion of bladder cancer cells and increases cisplatin sensitivity.
Wei X; Jiang Y; Yang G; Chang T; Sun G; Chen S; Wu S; Liu R
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17807-17821. PubMed ID: 37935937
[TBL] [Abstract][Full Text] [Related]
8. Rab23 is overexpressed in human astrocytoma and promotes cell migration and invasion through regulation of Rac1.
Wang M; Dong Q; Wang Y
Tumour Biol; 2016 Aug; 37(8):11049-55. PubMed ID: 26897750
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and biological roles of TRIM24 in human bladder carcinoma.
Xue D; Zhang X; Zhang X; Liu J; Li N; Liu C; Liu Y; Wang P
Tumour Biol; 2015 Sep; 36(9):6849-55. PubMed ID: 25846736
[TBL] [Abstract][Full Text] [Related]
10. miR‑367‑3p downregulates Rab23 expression and inhibits Hedgehog signaling resulting in the inhibition of the proliferation, migration, and invasion of prostate cancer cells.
Du W; Li D; Xie J; Tang P
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278506
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression.
Lee EJ; Lee SJ; Kim S; Cho SC; Choi YH; Kim WJ; Moon SK
Cell Signal; 2013 Oct; 25(10):2025-38. PubMed ID: 23770289
[TBL] [Abstract][Full Text] [Related]
12. Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-κB signaling.
Liu J; Gong X; Zhu X; Xue D; Liu Y; Wang P
Oncotarget; 2017 Sep; 8(43):75272-75283. PubMed ID: 29088864
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of hSNF2H in glioma promotes cell proliferation, invasion, and chemoresistance through its interaction with Rsf-1.
Zhao XC; An P; Wu XY; Zhang LM; Long B; Tian Y; Chi XY; Tong DY
Tumour Biol; 2016 Jun; 37(6):7203-12. PubMed ID: 26666816
[TBL] [Abstract][Full Text] [Related]
14. Dual role of TGFBR3 in bladder cancer.
Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of GGN promotes tumorigenesis in bladder cancer and is correlated with poor prognosis.
Wang W; Li C; Chen Y; Teng L; Cao Y; Xu Y; Pan H; An R
Gene; 2018 Apr; 652():7-15. PubMed ID: 29412153
[TBL] [Abstract][Full Text] [Related]
16. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
17. SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer.
Mukherjee N; Cardenas E; Bedolla R; Ghosh R
Oncotarget; 2017 Feb; 8(9):15114-15125. PubMed ID: 28122346
[TBL] [Abstract][Full Text] [Related]
18. NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
Cui X; Shen D; Kong C; Zhang Z; Zeng Y; Lin X; Liu X
Sci Rep; 2017 Jan; 7():40723. PubMed ID: 28139689
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
[TBL] [Abstract][Full Text] [Related]
20. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]